Europe’s small biotechs have leapt to take advantage of the European Medicines Agency’s (EMEA) office for SMEs, according to a review of its first year in operation.
Two of Europe’s gene therapy pioneers have reported significant progress in the last week, bringing commercial gene therapy products yet closer to reality.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.